Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00202891

Enrollment

Registered

2005-09-20

Start date

2007-05-31

Completion date

2007-09-30

Last updated

2015-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pyoderma

Keywords

pyoderma, sisomicin, nadifloxacin

Brief summary

This open-label, randomized, parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic, sisomicin cream, with that of another topical antibiotic cream, nadifloxacin cream, in the treatment of Indian patients with primary pyodermas.

Interventions

DRUGsisomicin

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients of either sex and suffering from primary pyodermas requiring topical antibiotic therapy without occlusive dressings. * \>=6 years of age. * Written informed consent.

Exclusion criteria

* Patients must not take any other antibiotics. * Patients should not be hypersensitive to any of the test drugs. * Patients are not to have any other investigational drug within one month of starting this study. * Patients cannot be enrolled more than once in the study. * Patients must not have any significant medical condition which, in the judgment of the investigator, might interfere with the study or require treatment. * Pregnant women and nursing mothers are to be excluded.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026